Abridge, a generative AI platform for clinical conversations, announced it raised a $250 million Series D investment.
The round was co-led by Elad Gil and IVP, with participation from Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health Ventures, K. Ventures, Lightspeed Venture Partners, NVentures (NVIDIA’s venture capital arm), Redpoint Ventures, Spark Capital and...
Diagnostics company LumiraDx announced it signed an agreement to sell its point-of-care technology to pharma giant Roche for $295 million, with an additional payment of $55 million to fund the platform until the acquisition closes.
LumiraDx developed a diagnostic testing system that uses a small, portable instrument and microfluidic test strips to perform multiple lab-quality tests via a single...
Sight Diagnostics, an Israeli startup developing a machine-vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round.
According to the company, this newest raise brings its lifetime funding to more than $124 million.
WHAT IT DOES
Founded in 2011, Sight Diagnostics offers an...
A multidisciplinary group of researchers have detailed a novel infectious disease diagnostic platform that relies on the user’s smartphone to provide point-of-care screening.
Housed within a portable 3D-printed cradle, the tool uses the smartphone and an app to interpret real-time images of a microfluidic chip embedded on credit card-like cartridge. Researchers say it's the only point-of-care...
PatientSafe Solutions, maker of mobile hospital workflow system PatientTouch, has secured a $3 million strategic investment and resale agreement from Telus Health, the healthcare arm of Canadian mobile operator Telus.
“This investment and exclusive reseller agreement is the latest validation of PatientSafe’s approach to supporting the future of healthcare on a global scale,” Joseph Condurso,...
One of the shifts that occurred in telecommunications once most people began to carry mobile phones was that we no longer only called places, we called people. Location no longer mattered us much, we can now make calls -- for better or worse -- from virtually anywhere.
A popular phrase in healthcare -- "point of care" -- has historically been a phrase that is very much tied to a particular...
The FDA cleared Abbott's i-STAT 1 Wireless point-of-care blood analyzer last week, marking the fourth wireless-enabled medical device to receive FDA clearance so far this year. Ascom, Monica Healthcare and Mobisante have each received a 510(k) clearance this year for a connected medical device. The FDA has cleared more than a dozen software apps for mobile devices over the years including one...
